World Wires · story 16044 · unverified · 1 source(s)

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Open in the desk

Coverage

• Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema GlobeNewswire: public companies · tier D · clear net · 2026-10-02 12:00 UTC

What this site indexes